TP53 and neoplasm: Moreover, functional inactivation of p73 in the cytoplasm identifies a potential therapeutic target: agents that restore nuclear localisation or transcriptional activity of p73 could reinstate tumour-suppressive programmes, particularly in tumours lacking functional p53 [9,10,11,13,18].